Re: Quantec VXS
Link: [https://collective2.com/details/110186894]
For a limited time the next ten (10) subscribers to VXS will lock-in our discounted subscription price of $89/month for a term of six (6) months. This offer will remain valid until December 6th, 2017 and may otherwise be terminated at our discretion.
Since launching on C2 in mid-March of this year, VXS has achieved a cumulative hypothetical return of over 50%* (please see disclaimer below regarding hypothetical results).
In comparison, the VelocityShares Daily Inverse VIX Short Term ETN (symbol: XIV) has gained approximately 70% with a max drawdown of 26.5% over the same period.
VXS is a long-only ETN volatility strategy with a long term objective of outperforming XIV on a risk-adjusted basis.
For additional information about the strategy or other related inquiries, please contact us.
Thank you,
Quantec
*DISCLAIMER:
These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.
In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program, which cannot be fully accounted for in the preparation of hypothetical performance results and all of which can adversely affect actual trading results.
Please see additional warnings on the C2 website about the risks of relying on hypothetical results. Hypothetical results can be vastly different than the real-life results you can achieve in your trading account, almost always for the worse.
